Brain & Nervous System Health Center

This article is from the WebMD News Archive

Font Size
A
A
A

Stem Cells May Help Reverse Paralysis

Tests Succeed in Paralyzed Rats; Method May Help People, Scientists Say
By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD

June 21, 2006 -- With some chemical help, embryonic stem cells may help reverse paralysis, tests done on paralyzed rats show.

The technique, described in the July issue of the Annals of Neurology, hasn't been tested on people yet.

But, based on the results seen in adult rats, the method may be a "potential therapeutic intervention for humans with paralysis," write the researchers. They include Deepa Deshpande, MS, MBIOT, and Douglas Kerr, MD, PhD, both of Johns Hopkins University in Baltimore, Md.

This isn't the first time scientists have tested stem cells in paralyzed animals. But the new study's method differs from that in past experiments.

Stem cells can develop into different types of cells, although embryonic stem cells may have a wider range of possibilities than adult stem cells.

Stem Cell Test

In this experiment, the scientists first did some lab work on embryonic mice stem cells. They used chemicals to tell the cells to become motor neurons, which are nerve cells that control muscles.

The mouse stem cells spent 3.5 days growing into motor neurons in the lab.

Then, researchers transplanted them into the spinal cords of 120 paralyzed adult rats.

As part of the experiment, the scientists created a key test group of 15 paralyzed rats. Those rats got a deluxe stem cell package souped up with three extras:

  • Chemical pretreatment of the stem cells to help new motor neurons survive
  • Chemicals to help the rats' bodies accept the stem cells
  • Chemicals that told the stem cells where to park to help one of the rats' hind paws

For comparison, the other rats got few or none of these additives with their stem cells.

Partial Reversal of Paralysis

Six months later, 11 of the 15 rats in the key test group could put weight on the paralyzed hind paw their stem cells had been instructed to target. Those rats could also step off from that paw.

None of the other rats in the study were able to do that.

But even in the key test group, paralysis recovery was only partial; the rats couldn't move the hind paw that hadn't been targeted by the stem cells.

Rats in the key test group made 125 new nerve connections to muscle, 50 of which reached and worked in the targeted hind paw.

The other rats had similar numbers of surviving, transplant-derived motor neurons. But without the full package of chemical perks, those motor neurons didn't bring paralysis recovery, the study showed.

In short, embryonic stem cells show promise against paralysis in rats, but it may take extra chemical help to get the biggest benefits.

webMD Video

Show or hide information about video: When Dizzy Equals Danger   When Dizzy Equals Danger

48x48_dizzy_diagnosis.jpg

Many people experience dizzy spells, but how much is too much? Learn when dizzy equals danger.

Watch Video: When Dizzy Equals Danger (opens in a new window)

Show or hide information about video: Brain Aneurysm Bypass   Brain Aneurysm Bypass

Show or hide information about video: Future of MS Treatment   Future of MS Treatment

Show or hide information about video: Progesterone for Brain Injuries   Progesterone for Brain Injuries

Show or hide information about video: Aging Brain Study   Aging Brain Study

Advertise on Fox News Channel, FOXNews.com and FOX News Radio Jobs at FOX News Channel. Internships at FOX News Channel (now accepting Fall interns).
Terms of use. Privacy Statement. For FOXNews.com comments write to foxnewsonline@foxnews.com; For FOX News Channel comments write to comments@foxnews.com
© Associated Press. All rights reserved.
SMARTMONEY ® © 2006 SmartMoney. SmartMoney is a joint publishing venture of Dow Jones & Company, Inc. and Hearst SM Partnership. All Rights Reserved.
All quotes delayed by 20 minutes. Delayed quotes provided by ComStock.
Historical prices and fundamental data provided by Hemscott, Inc.
Mutual fund data provided by Lipper. Mutual Fund NAVs are as of previous day's close.
Earnings estimates provided by Zacks Investment Research.
Upgrades and downgrades provided by Briefing.com.
This material may not be published, broadcast, rewritten, or redistributed. © 2006 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.